Results 21 to 30 of about 1,619,240 (186)

Treatment of gestational diabetes: oral hypoglycemic agents or insulin? [PDF]

open access: yes, 2011
Our report aims to verify whether perinatal maternal glycemic control in gestational diabetes can only be achieved with insulin or with oral hypoglycemic agents.
Renda, Eliana   +7 more
core   +1 more source

Second-line Medication Preference in Patients with Type 2 Diabetes: a Study Based on a Discrete Choice Experiment [PDF]

open access: yesZhongguo quanke yixue
Background With the continuous improvement of diabetes prevention and treatment strategies, clinical guidelines recommend first-line hypoglycemic agents while emphasizing a "patient-centered", and the selection of appropriate second-line ...
LIU Zhigang, LIU Shimeng, ZHENG Lyuyun, XUE Wenjing, CAO Chenchen, LIU Jing, CHEN Yingyao
doaj   +1 more source

Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

open access: yesBMJ Open Diabetes Research & Care, 2020
Introduction Differences in mortality and cause-specific mortality rates according to glycated albumin (GA) and hemoglobin A1c (HbA1c) levels among dialysis patients with diabetes based on hypoglycemic agent use and malnutrition status remain unclear ...
Takayuki Hamano   +6 more
doaj   +1 more source

Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

open access: yesCardiovascular Diabetology, 2023
Background Although sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular benefits in patients with type 2 diabetes mellitus, real-world evidence regarding their benefits to diabetic patients with acute myocardial infarction
Young Sang Lyu   +4 more
doaj   +1 more source

Bornyl-Containing Derivatives of Benzyloxyphenylpropanoic Acid as FFAR1 Agonists: In Vitro and In Vivo Studies

open access: yesPharmaceutics, 2023
Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases worldwide. Several classes of hypoglycemic drugs are used to treat it, but various side effects limit their clinical use.
Darya A. Pon’kina   +8 more
doaj   +1 more source

Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges

open access: yesDubai Diabetes and Endocrinology Journal, 2022
The prevalence of diabetes and diabetic nephropathy is increasing, especially in middle eastern countries. Many patients reach end-stage renal disease and either start dialysis or consider preemptive transplantation.
Alaaeldin M.K. Bashier   +5 more
doaj   +1 more source

Current status of diabetes treatment in Miyazaki Prefecture, Japan: Results of a questionnaire survey conducted in 2016 and 2020

open access: yesJournal of Diabetes Investigation, 2022
Aims/Introduction The Japanese diabetes treatment guidelines do not specify the first choice of hypoglycemic agents, unlike those of Western countries. Furthermore, the current situation in diabetes treatment is that the choice of hypoglycemic agents is ...
Yudai Uehira   +8 more
doaj   +1 more source

Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications

open access: yesJournal of Diabetes Research, 2022
Several epidemiological studies have identified diabetes as a risk factor for colorectal cancer (CRC). The potential pathophysiological mechanisms of this association include hyperinsulinemia, insulin-like growth factor (IGF) axis, hyperglycemia ...
Guan-Hua Yu   +3 more
doaj   +1 more source

A Review on Phytochemicals and Biological Properties of Golden Chamomile (Matricaria aurea) [PDF]

open access: yesResearch Journal of Pharmacognosy
Golden chamomile (Matricaria aurea) is widely distributed in Europe and Asia and is commonly used as an alternative to M. chamomilla in traditional medicine in some countries.
Saeed Ghasemi, Fatemeh Yousefbeyk*
doaj   +1 more source

Synthesis of Biguanides as Potential hypoglycemic Agents: Some heterocyclic Derivatives

open access: yes, 1966
Synthesis of Biguanides as Potential hypoglycemic Agents: Some heterocyclic ...
Auditi Kumar Acharyya   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy